The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients

<i>Background and Objectives:</i> On 24 March 2020, the United States Food and Drug Administration (FDA) announced the approval of convalescent plasma therapy for critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emergency investigational new drug. This...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Livius Tirnea, Felix Bratosin, Iulia Vidican, Bianca Cerbu, Mirela Turaiche, Madalina Timircan, Madalin-Marius Margan, Iosif Marincu
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	MDPI AG 2021-03-01
Цуврал:	Medicina
Нөхцлүүд:	convalescent plasma COVID-19 critically ill transfusion SARS CoV-2
Онлайн хандалт:	https://www.mdpi.com/1648-9144/57/3/257
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!